Five things for pharma marketers to know: Tuesday, March 14, 2017
1. Pershing Square Capital Management sold its entire stake in Valeant Pharmaceutical Industries. That firm lost about $4 billion in two years as a result of its stake in the drugmaker. ( NYT )
2. Novartis received FDA approval to market a combination of its experimental drug kisqali and letrozole to treat breast cancer in postmenopausal women as a first-line treatment. More than half of patients achieved progression-free survival in a late-stage trial. ( Reuters )
3. Express Scripts...